An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN study.
Gynecol Oncol
; 159(3): 721-731, 2020 12.
Article
in En
| MEDLINE
| ID: mdl-32988624
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Phthalazines
/
Piperazines
/
Biomarkers, Tumor
/
Endometrial Neoplasms
/
Neoadjuvant Therapy
/
Poly(ADP-ribose) Polymerase Inhibitors
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged80
Language:
En
Journal:
Gynecol Oncol
Year:
2020
Document type:
Article